gavreto
roche registration gmbh - pralsetinib - Карцином, недребноклетъчен белодроб - Антинеопластични средства - gavreto is indicated as monotherapy for the treatment of adult patients with rearranged during transfection (ret) fusion-positive advanced non-small cell lung cancer (nsclc) not previously treated with a ret inhibitor.
setinin 100 mg film - coated tablets
actavis group ptc ehf. - Кветиапин - 100 mg film - coated tablets
setinin 200 mg film - coated tablets
actavis group ptc ehf. - Кветиапин - 200 mg film - coated tablets
teysuno
nordic group b.v. - тегафур, gimeracil, oteracil - Стомашни неоплазми - Антинеопластични средства - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.
setinin 150 mg film - coated tablets
150 mg film - coated tablets
setinin 25 mg film - coated tablets
25 mg film - coated tablets
setinin 300 mg film - coated tablets
300 mg film - coated tablets
secondelle 1500 micrograms tablet
laboratorios leon farma sa - Левоноргестрел - 1500 micrograms tablet